Jade Biosciences, a clinical-stage biotech company developing therapies for autoimmune diseases, announced its participation in several upcoming healthcare conferences in November 2026, including Guggenheim, Stifel, UBS, and Jefferies events. The company will host fireside chats and one-on-one investor meetings, with live webcasts available on its website. Jade's lead drug candidate, JADE101, targets immunoglobulin A nephropathy, with additional therapies in development. These presentations aim to update investors on progress and future plans, supporting continued interest and investment in the company.
Jade Biosciences' upcoming conference participation is contextually set against the health sector's market activity on Pluang. Of 150 priced health-sector US stocks, 74 rose and 69 fell today. Notable movers include Neurocrine Biosciences Inc (NBIX) at USD 154.08 with a 6.01% increase and 100% sell order activity, Koninklijke Philips NV (PHG) at USD 29.23 up 5.94%, and Inovio Pharmaceuticals Inc (INO) at USD 1.78 down 5.56%. These figures are as of Nov 03, 2026 19:02 WIB.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
